123 related articles for article (PubMed ID: 35784258)
1. Factors Associated With Late Antiretroviral Therapy Initiation Among People Living With HIV in Southern Iran: A Historical Cohort Study.
Afrashteh S; Fararouei M; Ghaem H; Gheibi Z
Front Public Health; 2022; 10():881069. PubMed ID: 35784258
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with late initiation of antiretroviral therapy in Iran's HIV/AIDS surveillance data.
Sharafi M; Mirahmadizadeh A; Hassanzadeh J; Seif M; Heiran A
Sci Rep; 2024 Jan; 14(1):199. PubMed ID: 38167855
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with late antiretroviral therapy initiation in Cameroon: a representative multilevel analysis.
Ndawinz JD; Chaix B; Koulla-Shiro S; Delaporte E; Okouda B; Abanda A; Tchomthe S; Mboui E; Costagliola D; Supervie V
J Antimicrob Chemother; 2013 Jun; 68(6):1388-99. PubMed ID: 23391713
[TBL] [Abstract][Full Text] [Related]
4. Factors Associated With Delayed and Late Initiation of Antiretroviral Therapy Among Patients With HIV in Beijing, China, 2010-2020.
Mi Y; Zhou M; Zeng Y; Wang P; Gao L; Cheng F
Int J Public Health; 2023; 68():1605824. PubMed ID: 37416802
[No Abstract] [Full Text] [Related]
5. Factors associated with delayed and late ART initiation among people living with HIV in BC: results from the engage study.
Kesselring S; Osborne C; Bever A; Salters K; Cui Z; Chia J; Moore DM; Parashar S; Kaida A; Samji H; Duddy J; Gabler K; Howard T; Nash D; McCandless LC; Patterson TL; Corneil T; Montaner JSG; Hogg RS
AIDS Care; 2019 Jul; 31(7):885-892. PubMed ID: 30466303
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with late antiretroviral therapy initiation among adults in Mozambique.
Lahuerta M; Lima J; Nuwagaba-Biribonwoha H; Okamura M; Alvim MF; Fernandes R; Assan A; Hoos D; Elul B; El-Sadr WM; Nash D
PLoS One; 2012; 7(5):e37125. PubMed ID: 22615917
[TBL] [Abstract][Full Text] [Related]
7. Trends in baseline CD4 cell counts and risk factors for late antiretroviral therapy initiation among HIV-positive patients in Shanghai, a retrospective cross-sectional study.
Sun J; Liu L; Shen J; Chen P; Lu H
BMC Infect Dis; 2017 Apr; 17(1):285. PubMed ID: 28420350
[TBL] [Abstract][Full Text] [Related]
8. Early mortality after late initiation of antiretroviral therapy in the TREAT Asia HIV Observational Database (TAHOD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) Asia-Pacific.
Rupasinghe D; Kiertiburanakul S; Kamarulzaman A; Zhang F; Kumarasamy N; Chaiwarith R; Merati TP; Do CD; Khusuwan S; Avihingsanon A; Lee MP; Ly PS; Yunihastuti E; Nguyen KV; Ditangco R; Chan YJ; Pujari S; Ng OT; Choi JY; Sim B; Tanuma J; Sangle S; Ross J; Law M
HIV Med; 2020 Jul; 21(6):397-402. PubMed ID: 31852025
[TBL] [Abstract][Full Text] [Related]
9. AIDS-defining events among people living with HIV who have been under continuous antiretroviral therapy for more than one year, a German cohort study 1999-2018.
Pantke A; Kollan C; Gunsenheimer-Bartmeyer B; Jensen BO; Stephan C; Degen O; Schürmann D; Kurth T; Bremer V; Koppe U;
Infection; 2024 Apr; 52(2):637-648. PubMed ID: 38381307
[TBL] [Abstract][Full Text] [Related]
10. Late initiation of combination antiretroviral therapy in Canada: a call for a national public health strategy to improve engagement in HIV care.
Cescon A; Patterson S; Davey C; Ding E; Raboud JM; Chan K; Loutfy MR; Cooper C; Burchell AN; Palmer AK; Tsoukas C; Machouf N; Klein MB; Rourke SB; Rachlis A; Hogg RS; Montaner JS;
J Int AIDS Soc; 2015; 18(1):20024. PubMed ID: 26443752
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of patients infected with HIV through use of injected drugs compared to patients infected through sexual transmission: late presentation, delayed anti-retroviral treatment and higher mortality.
Suárez-García I; Sobrino-Vegas P; Dalmau D; Rubio R; Iribarren JA; Blanco JR; Gutierrez F; Montero Alonso M; Bernal E; Vinuesa García D; Del Amo J;
Addiction; 2016 Jul; 111(7):1235-45. PubMed ID: 26890155
[TBL] [Abstract][Full Text] [Related]
12. Trends and factors associated with initiation of HIV treatment among PLHIV in Jamaica, 2015-2019.
Cushnie A; Reintjes R; Figueroa JP; Artama M
PLoS One; 2023; 18(5):e0265468. PubMed ID: 37235603
[TBL] [Abstract][Full Text] [Related]
13. "Late for testing, early for antiretroviral therapy, less likely to die": results from a large HIV cohort study in China, 2006-2014.
Tang H; Mao Y; Tang W; Han J; Xu J; Li J
BMC Infect Dis; 2018 Jun; 18(1):272. PubMed ID: 29895275
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with initiation of antiretroviral therapy in the advanced stages of HIV infection in six Ethiopian HIV clinics, 2012 to 2013.
Nash D; Tymejczyk O; Gadisa T; Kulkarni SG; Hoffman S; Yigzaw M; Elul B; Remien RH; Lahuerta M; Daba S; El Sadr W; Melaku Z
J Int AIDS Soc; 2016; 19(1):20637. PubMed ID: 27113335
[TBL] [Abstract][Full Text] [Related]
15. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of Adverse Drug Reactions to Highly Active Antiretroviral Therapy (HAART) among HIV Positive Patients in Imam Khomeini Hospital of Tehran, Iran.
Koochak HE; Babaii A; Pourdast A; Golrokhy R; Rasoolinejad M; Khodaei S; Moghadam SRJ; Taheri RR; Seyed Alinaghi SA
Infect Disord Drug Targets; 2017; 17(2):116-119. PubMed ID: 28164754
[TBL] [Abstract][Full Text] [Related]
17. Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy.
Saracino A; Zaccarelli M; Lorenzini P; Bandera A; Marchetti G; Castelli F; Gori A; Girardi E; Mussini C; Bonfanti P; Ammassari A; d'Arminio Monforte A;
BMC Public Health; 2018 Jul; 18(1):870. PubMed ID: 30005709
[TBL] [Abstract][Full Text] [Related]
18. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
[TBL] [Abstract][Full Text] [Related]
19. HIV-associated anaemia before and after initiation of antiretroviral therapy at Art Centre of Minilik II Hospital, Addis Ababa, Ethiopia.
Adane A; Desta K; Bezabih A; Gashaye A; Kassa D
Ethiop Med J; 2012 Jan; 50(1):13-21. PubMed ID: 22519158
[TBL] [Abstract][Full Text] [Related]
20. Association of antiretroviral therapy with anal high-risk human papillomavirus, anal intraepithelial neoplasia, and anal cancer in people living with HIV: a systematic review and meta-analysis.
Kelly H; Chikandiwa A; Alemany Vilches L; Palefsky JM; de Sanjose S; Mayaud P
Lancet HIV; 2020 Apr; 7(4):e262-e278. PubMed ID: 32109408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
